El Salvador vs France: Cause of death, by non-communicable diseases, ages 0-4, female
El Salvador
36.4%
in 2021
France
36.4%
in 2021
El Salvador rank
62nd
France rank
64th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- El Salvador
- France
How they compare
El Salvador currently reports 36.4% against 36.4% in France, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was France ahead.
El Salvador ranks 62nd and France ranks 64th of 185 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.8% | 44.3% | 22.5% | France |
| 2010s | 35.1% | 37.8% | 2.7% | France |
| 2020s | 36.3% | 36.7% | 0.4% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, El Salvador or France?
- El Salvador, at 36.4% against 36.4% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between El Salvador and France?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and France?
- 6 years are reported by both, from 2000 to 2021.
- How do El Salvador and France rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- El Salvador ranks 62nd and France ranks 64th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.